同調培養されたチャイニーズハムスターDon細胞から分裂中期染色体の分離〔英文〕
スポンサーリンク
概要
- 論文の詳細を見る
In order to obtain large quantities of metaphase chromosomes, we have established the optimum conditions for obtaining a large mitotic cell population from cultured Chinese hamster Don cells (CH-Don-13 clone) by two treatments with a combination of colcemid and harvesting techniques: after pretreatment of a given number of CH-Don-13 cells with 0.025μg/ml of colcemid for 6 hours, the first mitotic cell population was collected by harvesting and the remaining cell population was again treated with 0.025 μg/ml of colcemid for 4 hours; then the second mitotic cell population was collected by harvesting and combined with the first mitotic cell population kept at 0° to 4°C. Mitotic cells obtained by this method showed no significant biological or cytological damage, and the chromosomes isolated from these cell populations were morphologically intact.
- 日本遺伝学会の論文
著者
-
堀川 正克
Division of Radiation Biology, Faculty of Pharmaceutical Sciences, Kanazawa University
-
HORIKAWA MASAKATSU
Division of Radiation Biology, Faculty of Pharmaceutical Sciences, Kanazawa University
-
SAKAMOTO TAKASHI
Division of Radiation Biology, Faculty of Pharmaceutical Sciences, Kanazawa University
-
坂本 好史
Division of Radiation Biology, Faculty of Pharmaceutical Sciences, Kanazawa University
関連論文
- チャイニ-ズハムスタ-細胞における放射線誘発致死障害および突然変異障害の回復〔英文〕
- 体細胞突然変異の研究-1-培養されたチャイニ-ズハムスタ-hai細胞における放射線および化学物質による栄養要求性ならびに非要求性突然変異の誘発〔英文〕
- 培養されたヒト由来細胞株(XP細胞とHeLaS3細胞)におけるX線誘発細胞死と突然変異〔英文〕
- 同調培養されたチャイニーズハムスターDon細胞から分裂中期染色体の分離〔英文〕
- ISOLATION AND CHARACTERIZATION OF NUTRITIONALLY DEFICIENT CELLS FROM CULTURED CHINESE HAMSTER HAI CELLS BY A REPLICA PLATING METHOD
- STUDIES ON SOMATIC CELL MUTATIONS:II. RADIATION-INDUCTION OF 8-AZAGUANINE-RESISTANT AND -SENSITIVE MUTANTS IN CHINESE HAMSTER HAI CELLS IN VITRO
- Refractory Evans Syndrome after Autologous Stem Cell Transplantation for Multiple Myeloma: Management with a Second Transplantation
- Leukemic and Meningeal Relapse of CD5^+ Intravascular Large B-Cell Lymphoma with Down-Modulation of CD20 after Rituximab Therapy